share_log

HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $49

Benzinga ·  May 12, 2023 06:22

HC Wainwright & Co. analyst Edward White maintains Cullinan Oncology (NASDAQ:CGEM) with a Buy and lowers the price target from $50 to $49.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment